Evidence map›Paper›PMID 28902587›Full record

ArticleThe New England journal of medicine2017

Hospital-Readmission Risk - Isolating Hospital Effects from Patient Effects.

Harlan M Krumholz, Kun Wang, Zhenqiu Lin, Kumar Dharmarajan, Leora I Horwitz, Joseph S Ross, Elizabeth E Drye, Susannah M Bernheim, Sharon-Lise T Normand

Abstract read
In one paragraph

Article in The New England journal of medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. MONITORING FOR WASTE: EVIDENCE FROM MEDICARE AUDITS.The quarterly journal of economics · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Harlan M KrumholzFrom the Sections of Cardiovascular Medicine (H.M.K., K.W., K.D.) and General Internal Medicine (J.S.R., S.M.B.) and the National Clinician Scholars Program (J.S.R., S.M.B.), Department of Internal Medicine, and the Department of Pediatrics (E.E.D.), Yale School of Medicine, the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K., K.W., Z.L., K.D., J.S.R., E.E.D., S.M.B.), and the Department of Health Policy and Management, Yale School of Public Health (H.M.K., J.S.R.) - all in New Haven, CT; Clover Health, Jersey City, NJ (K.D.); the Division of Healthcare Delivery Science, Department of Population Health, and the Division of General Internal Medicine and Clinical Innovation, Department of Medicine, New York University (NYU) School of Medicine, Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York (L.I.H.); and the Department of Health Care Policy, Harvard Medical School, and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston (S.-L.T.N.).
Kun WangFrom the Sections of Cardiovascular Medicine (H.M.K., K.W., K.D.) and General Internal Medicine (J.S.R., S.M.B.) and the National Clinician Scholars Program (J.S.R., S.M.B.), Department of Internal Medicine, and the Department of Pediatrics (E.E.D.), Yale School of Medicine, the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K., K.W., Z.L., K.D., J.S.R., E.E.D., S.M.B.), and the Department of Health Policy and Management, Yale School of Public Health (H.M.K., J.S.R.) - all in New Haven, CT; Clover Health, Jersey City, NJ (K.D.); the Division of Healthcare Delivery Science, Department of Population Health, and the Division of General Internal Medicine and Clinical Innovation, Department of Medicine, New York University (NYU) School of Medicine, Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York (L.I.H.); and the Department of Health Care Policy, Harvard Medical School, and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston (S.-L.T.N.).
Zhenqiu LinFrom the Sections of Cardiovascular Medicine (H.M.K., K.W., K.D.) and General Internal Medicine (J.S.R., S.M.B.) and the National Clinician Scholars Program (J.S.R., S.M.B.), Department of Internal Medicine, and the Department of Pediatrics (E.E.D.), Yale School of Medicine, the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K., K.W., Z.L., K.D., J.S.R., E.E.D., S.M.B.), and the Department of Health Policy and Management, Yale School of Public Health (H.M.K., J.S.R.) - all in New Haven, CT; Clover Health, Jersey City, NJ (K.D.); the Division of Healthcare Delivery Science, Department of Population Health, and the Division of General Internal Medicine and Clinical Innovation, Department of Medicine, New York University (NYU) School of Medicine, Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York (L.I.H.); and the Department of Health Care Policy, Harvard Medical School, and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston (S.-L.T.N.).
Kumar DharmarajanFrom the Sections of Cardiovascular Medicine (H.M.K., K.W., K.D.) and General Internal Medicine (J.S.R., S.M.B.) and the National Clinician Scholars Program (J.S.R., S.M.B.), Department of Internal Medicine, and the Department of Pediatrics (E.E.D.), Yale School of Medicine, the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K., K.W., Z.L., K.D., J.S.R., E.E.D., S.M.B.), and the Department of Health Policy and Management, Yale School of Public Health (H.M.K., J.S.R.) - all in New Haven, CT; Clover Health, Jersey City, NJ (K.D.); the Division of Healthcare Delivery Science, Department of Population Health, and the Division of General Internal Medicine and Clinical Innovation, Department of Medicine, New York University (NYU) School of Medicine, Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York (L.I.H.); and the Department of Health Care Policy, Harvard Medical School, and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston (S.-L.T.N.).
Leora I HorwitzFrom the Sections of Cardiovascular Medicine (H.M.K., K.W., K.D.) and General Internal Medicine (J.S.R., S.M.B.) and the National Clinician Scholars Program (J.S.R., S.M.B.), Department of Internal Medicine, and the Department of Pediatrics (E.E.D.), Yale School of Medicine, the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K., K.W., Z.L., K.D., J.S.R., E.E.D., S.M.B.), and the Department of Health Policy and Management, Yale School of Public Health (H.M.K., J.S.R.) - all in New Haven, CT; Clover Health, Jersey City, NJ (K.D.); the Division of Healthcare Delivery Science, Department of Population Health, and the Division of General Internal Medicine and Clinical Innovation, Department of Medicine, New York University (NYU) School of Medicine, Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York (L.I.H.); and the Department of Health Care Policy, Harvard Medical School, and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston (S.-L.T.N.).
Joseph S RossFrom the Sections of Cardiovascular Medicine (H.M.K., K.W., K.D.) and General Internal Medicine (J.S.R., S.M.B.) and the National Clinician Scholars Program (J.S.R., S.M.B.), Department of Internal Medicine, and the Department of Pediatrics (E.E.D.), Yale School of Medicine, the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K., K.W., Z.L., K.D., J.S.R., E.E.D., S.M.B.), and the Department of Health Policy and Management, Yale School of Public Health (H.M.K., J.S.R.) - all in New Haven, CT; Clover Health, Jersey City, NJ (K.D.); the Division of Healthcare Delivery Science, Department of Population Health, and the Division of General Internal Medicine and Clinical Innovation, Department of Medicine, New York University (NYU) School of Medicine, Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York (L.I.H.); and the Department of Health Care Policy, Harvard Medical School, and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston (S.-L.T.N.).
Elizabeth E DryeFrom the Sections of Cardiovascular Medicine (H.M.K., K.W., K.D.) and General Internal Medicine (J.S.R., S.M.B.) and the National Clinician Scholars Program (J.S.R., S.M.B.), Department of Internal Medicine, and the Department of Pediatrics (E.E.D.), Yale School of Medicine, the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K., K.W., Z.L., K.D., J.S.R., E.E.D., S.M.B.), and the Department of Health Policy and Management, Yale School of Public Health (H.M.K., J.S.R.) - all in New Haven, CT; Clover Health, Jersey City, NJ (K.D.); the Division of Healthcare Delivery Science, Department of Population Health, and the Division of General Internal Medicine and Clinical Innovation, Department of Medicine, New York University (NYU) School of Medicine, Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York (L.I.H.); and the Department of Health Care Policy, Harvard Medical School, and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston (S.-L.T.N.).
Susannah M BernheimFrom the Sections of Cardiovascular Medicine (H.M.K., K.W., K.D.) and General Internal Medicine (J.S.R., S.M.B.) and the National Clinician Scholars Program (J.S.R., S.M.B.), Department of Internal Medicine, and the Department of Pediatrics (E.E.D.), Yale School of Medicine, the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K., K.W., Z.L., K.D., J.S.R., E.E.D., S.M.B.), and the Department of Health Policy and Management, Yale School of Public Health (H.M.K., J.S.R.) - all in New Haven, CT; Clover Health, Jersey City, NJ (K.D.); the Division of Healthcare Delivery Science, Department of Population Health, and the Division of General Internal Medicine and Clinical Innovation, Department of Medicine, New York University (NYU) School of Medicine, Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York (L.I.H.); and the Department of Health Care Policy, Harvard Medical School, and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston (S.-L.T.N.).
Sharon-Lise T NormandFrom the Sections of Cardiovascular Medicine (H.M.K., K.W., K.D.) and General Internal Medicine (J.S.R., S.M.B.) and the National Clinician Scholars Program (J.S.R., S.M.B.), Department of Internal Medicine, and the Department of Pediatrics (E.E.D.), Yale School of Medicine, the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K., K.W., Z.L., K.D., J.S.R., E.E.D., S.M.B.), and the Department of Health Policy and Management, Yale School of Public Health (H.M.K., J.S.R.) - all in New Haven, CT; Clover Health, Jersey City, NJ (K.D.); the Division of Healthcare Delivery Science, Department of Population Health, and the Division of General Internal Medicine and Clinical Innovation, Department of Medicine, New York University (NYU) School of Medicine, Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York (L.I.H.); and the Department of Health Care Policy, Harvard Medical School, and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston (S.-L.T.N.).

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Understanding hospital value: provider, hospital and community effectsR01HS022882 · AHRQ · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HORWITZ, LEORA · 2014 to 2023
$2.9M
AHRQ HHS R01 HS022882NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundTo isolate hospital effects on risk-standardized hospital-readmission rates, we examined readmission outcomes among patients who had multiple admissions for a similar diagnosis at more than one hospital within a given year.

methodsWe divided the Centers for Medicare and Medicaid Services hospital-wide readmission measure cohort from July 2014 through June 2015 into two random samples. All the patients in the cohort were Medicare recipients who were at least 65 years of age. We used the first sample to calculate the risk-standardized readmission rate within 30 days for each hospital, and we classified hospitals into performance quartiles, with a lower readmission rate indicating better performance (performance-classification sample). The study sample (identified from the second sample) included patients who had two admissions for similar diagnoses at different hospitals that occurred more than 1 month and less than 1 year apart, and we compared the observed readmission rates among patients who had been admitted to hospitals in different performance quartiles.

resultsIn the performance-classification sample, the median risk-standardized readmission rate was 15.5% (interquartile range, 15.3 to 15.8). The study sample included 37,508 patients who had two admissions for similar diagnoses at a total of 4272 different hospitals. The observed readmission rate was consistently higher among patients admitted to hospitals in a worse-performing quartile than among those admitted to hospitals in a better-performing quartile, but the only significant difference was observed when the patients were admitted to hospitals in which one was in the best-performing quartile and the other was in the worst-performing quartile (absolute difference in readmission rate, 2.0 percentage points; 95% confidence interval, 0.4 to 3.5; P=0.001).

conclusionsWhen the same patients were admitted with similar diagnoses to hospitals in the best-performing quartile as compared with the worst-performing quartile of hospital readmission performance, there was a significant difference in rates of readmission within 30 days. The findings suggest that hospital quality contributes in part to readmission rates independent of factors involving patients. (Funded by Yale-New Haven Hospital Center for Outcomes Research and Evaluation and others.).

Indexed as

Patient ReadmissionQuality Indicators, Health CareAgedHospitalsHumansOutcome Assessment, Health CareRisk AdjustmentUnited States

Identifiers

PMID28902587
PMCPMC5671772

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.